Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Follitropin Beta · Follistim

Recombinant protein · Agonist of follicle-stimulating hormone receptor (FSHR) · developed by Organon Usa

Approved FDA, Sep 1997
OGN Developer
2 Registered trials

What is Follitropin Beta?

Follitropin beta is a recombinant follicle-stimulating hormone given by subcutaneous injection in fixed daily doses during ovarian stimulation. It acts on the follicle-stimulating hormone receptor to stimulate follicle development. It is studied in female infertility and ovarian function insufficiency.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Follistim, FOLLISTIM AQ
Drug type
Recombinant protein
Targets
follicle-stimulating hormone receptor (FSHR)
Mechanism
Agonist of follicle-stimulating hormone receptor (FSHR)
Pathways
ovarian follicle stimulation
Therapy area
Renal & urology
Developer
Organon Usa Inc (OGN)
FDA status
Approved as Follistim (September 29, 1997), BLA020582
UNII
QR8T22JM5W

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05330130 Phase 1 Ovarian Function Insufficiency Completed OGN
NCT00703014 N/A Pregnancy Completed OGN

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Fertility IssuesInfertilityInfertility,FemaleNeonatesOvarian Function InsufficiencyPregnancy

Other drugs acting on FSHR

More from Organon Usa

Sources

Updated Oct 25, 2026. Something wrong or missing? Report it on the OGN page.

Follow OGN, the company behind Follitropin Beta

See OGN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

OGN catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.